Insulin Glulisine (Cartridges and Pens) and Ramucirumab Intravenous
Determining the interaction of Insulin Glulisine (Cartridges and Pens) and Ramucirumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glulisine
Brand name: Apidra, Apidra OptiClik Cartridge, Apidra SoloStar Pen
Synonyms: Insulin glulisine, Insulin Glulisine
Generic Name: ramucirumab
Brand name: Cyramza
Synonyms: Ramucirumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Glulisine (Cartridges and Pens)-Ranexa
- Insulin Glulisine (Cartridges and Pens)-Ranibizumab
- Insulin Glulisine (Cartridges and Pens)-Ranibizumab Intraocular
- Insulin Glulisine (Cartridges and Pens)-Ranibizumab ophthalmic
- Insulin Glulisine (Cartridges and Pens)-Ranitidine
- Insulin Glulisine (Cartridges and Pens)-Ranitidine Capsule
- Ramucirumab Intravenous-Insulin Glulisine (Vials)
- Ramucirumab Intravenous-Insulin glulisine Subcutaneous
- Ramucirumab Intravenous-Insulin human inhaled Inhalation
- Ramucirumab Intravenous-Insulin human regular Injection
- Ramucirumab Intravenous-Insulin inhalation
- Ramucirumab Intravenous-Insulin isophane